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To gain insights in the relationships of specific amino acid residues with the active site of the mitochondrial ornithine/citrulline carrier, we
studied the effect of specific protein modifying reagents on the transport catalysed by the carrier reconstituted into liposomes. It was found that,
besides the sulfhydryl reagents NEM, MTSEA, p-hydroxymercuribenzoate, diamide also the lysine reagents PLP, DIDS, SITS, the carboxyl
reagents WRK, EDC and the arginine reagent methylglyoxal inhibited the carrier. NEM, MTSEA and PLP inhibited the ornithine/citrulline carrier
with a completely competitive type of mechanism. A 1:1 interaction of NEM with the carrier molecule has been demonstrated. The results are in
agreement with the localization of one sulfhydryl and at least one amino group in the substrate binding site. On the basis of the interferences
between SH reagents and PLP in the transport inhibition, it has been deduced that the distance between the SH and the NH2 residues of the active
site should be comparable to the distance between the g-NH2 and COOH residues of the ornithine molecule. The structural model of the ornithine/
citrulline carrier has been obtained by homology modelling using as template the ADP/ATP carrier structure. The combined analysis of the
experimental data and the structural model allows to deduce that Cys-132 is located in the substrate binding site, flanked by at least one Lys
residue.
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The ornithine/citrulline carrier is a metabolite transport
system of the inner mitochondrial membrane. The carrier
protein has been identified, purified and functionally charac-
terized in reconstituted liposomes [1]. The amino acid
sequences of the yeast ARG-11 [2] and the human ORNT10005-2736/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2005.10.007
Abbreviations: p-OHMB, p-hydroxymercuribenzoate; MTSEA, (2-ami-
noethyl)methanethiosulfonate hydrobromide; NEM, N-ethylmaleimide; DTE,
1.4-dithioerythritol; PLP, pyridoxal 5-phosphate; SITS, 4-acetamido-4V-iso-
thiocyanato-2,2V-stilbenedisulfonic acid; DIDS, 4,4V-diisothiocyanato-stilbene-
2,2V-disulfonic acid; WRK, Woodward’s reagent K; EDC, 1-ethyl-3(3-
dimethylaminopropyl)carbodiimmide
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E-mail address: indiveri@unical.it (C. Indiveri).[3] ornithine carriers have been identified; they show the
structural properties of the mitochondrial carrier family [4].
The mammalian ornithine/citrulline carrier plays an impor-
tant role in the urea cycle as it was proposed by functional
studies in intact mitochondria and in reconstituted liposomes
[1,5–7] and confirmed by the finding that deficiency of
ORNT1 gene lead to HHH syndrome [3] and that the hormonal
regulation of the ORNT1 expression in liver is integrated with
that of the urea cycle enzymes [8].
The carrier function has been extensively characterized in
reconstituted liposomes. The ornithine/citrulline antiport
catalysed by the carrier is electroneutral, since citrulline is
cotransported with an H+ [6]. The antiport reaction follows a
simultaneous (sequential) transport mechanism [9] as all but
one of the mitochondrial carriers characterized so far [4].
The ornithine/citrulline carrier is functionally asymmetrical;
the transport protein is inserted in the liposomal membraneta 1718 (2005) 53 – 60
http://www
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affinities on the two sides of the carrier are in line with the
hypothetical channelling of the urea cycle substrates among
the enzymes and the transport system [9–11].
The carrier catalyses also an electroneutral ornithine/H+
exchange that is active in the absence of countersubstrate
and should play the function of exporting ornithine from
the mitochondria to be used for the polyamine synthesis
[12].
Recently, by chemical modification of thiol groups [13],
we have shown that the ornithine/citrulline carrier possesses
three populations of SH groups: the first population leads to
inhibition of the physiological transport upon chemical
modification of one or more SH groups; the second is
responsible for the transition from carrier to pore-like
function; the third is involved in the formation of dis-
ulphides, leading to transport inhibition. The presence of
three distinct population of SH groups is a peculiar property
of the ornithine/citrulline carrier related with the presence, in
the amino acid sequence, of 9 Cys that is the highest
number of Cys residues of functionally known mitochondrial
carriers [13]. Thus, it would be interesting to investigate the
possible relationships of some of the SH residues with the
substrate binding site. In this paper, by a strategy based on
the kinetic analysis of the transport inhibition, it has been
revealed that one SH group is located in the substrate
binding site. Furthermore, the involvement of amino group(s)
of Lys in the transport function and its spatial relationship
with the SH group located in the active site have been
evidenced. The results are discussed on the light of the
structural homology model of the ornithine/citrulline carrier
based on the X-ray structure of the mitochondrial ADP/ATP
carrier [14].
2. Materials and methods
2.1. Materials
Hydroxyapatite (Bio-Gel HTP) and Bio-Beads SM-2 were purchased from
Bio-Rad, Celite 535 from Roth, DEAE-Sephacel, Sephadex PD-10, Sephadex
G-50 and G-75 from Pharmacia, L-[2,3-3H]ornithine, L-[ureido-14C]citrulline,
egg yolk phospholipids (L-a-phosphatidylcholine from fresh turkey egg yolk),
HEPES and Triton X-100 from Sigma, MTSEA from Toronto Research
Chemicals (North York, Ontario, Canada). All other reagents were of analytical
grade.
2.2. Purification and reconstitution of the ornithine/citrulline carrier
The ornithine/citrulline carrier was purified from rat liver mitochondria as
previously described [1]. The purified protein was reconstituted into liposomes
by removing the detergent with a hydrophobic column [15,16]. In this
procedure, the mixed micelles containing detergent, protein and phospholipids
were repeatedly passed through a column filled with Bio-Beads SM-2 resin.
The composition of the initial mixture used for reconstitution was: 400 Al of
purified protein in 3% Triton X-100 (Celite eluate, about 1 Ag protein), 100 Al of
10% egg yolk phospholipids in the form of sonicated liposomes prepared as
previously described [16], 30 mM l-ornithine (intraliposomal substrate) and
20 mM HEPES pH 8.0 (unless otherwise indicated) in a final volume of 700
Al. After vortexing, this mixture was passed 14 times through the same Bio-
Beads SM-2 column (0.53.2 cm), preequilibrated with the same buffer and
substrate present in the initial mixture. All the operations were performed at4 -C, except the passages through Bio-Beads SM-2 column that were
performed at room temperature.
2.3. Transport measurements
The external substrate was removed by passing 550 Al of proteoliposomes
through a Sephadex G-75 column (0.715 cm) preequilibrated with 10 mM
HEPES pH 8.0 (unless otherwise indicated) and 60 mM sucrose to balance
the internal osmolarity. The first 600 Al of the turbid eluate from the
Sephadex column were collected, transferred to reaction vessels (100 Al each),
and readily used for transport measurements by the inhibitor stop method
[17]. Transport was initiated by adding either 10 Al of [3H]ornithine
(ornithine/ornithine antiport) or 10 Al of [14C]citrulline (ornithine/citrulline
antiport) at the final concentration indicated in the legends to Tables and
Figures. After the required time interval, the reaction was stopped by adding
5 Al PLP plus 5 Al NEM at the final concentration of 20 mM and 1 mM,
respectively. In control samples, the inhibitor was added together with the
labeled substrate at time zero. The assay temperature was 25 -C. The external
radioactivity was removed by passing the samples (100 Al) through a
Sephadex G-50 column (0.68 cm). The liposomes eluted with 1.2 ml of 40
mM NaCl were collected in 4 ml of scintillation mixture, vortexed and
counted. The experimental values were corrected by subtracting the respective
control values. The antiport rate was evaluated from the radioactivity taken up
by the proteoliposomes in 1 min.
2.4. Other methods
The protein was determined by the Lowry method, modified for the
presence of non-ionic detergents [18]. The size of the substrate and reagent
molecules were calculated by using the ACD/ChemSketch 5.12 software. The
structural model of the ornithine/citrulline carrier was analysed by the Swiss-
Pdb Viewer 3.7; the same software was used to deduce the distances among
amino acid residues of the protein.
3. Results
3.1. Effect of specific reagents on the mitochondrial ornithine/
citrulline carrier
It was previously found that a number of SH reagents are
very effective inhibitors of the ornithine/citrulline carrier in a
concentration-dependent manner [13]. Here, the analysis of
modification of amino acid residues was extended by using
reagents selected among the most common inhibitors that react
with lysine (PLP, SITS, DIDS [19,20]), cysteine (NEM,
pOHMB, MTSEA, diamide [13,21]), arginine (methylglyoxal
[22]) and glutamate or aspartate (WRK [23], EDC [20])
functional groups (Table 1). To obtain IC50 values for each
inhibitor, the [3H]ornithine uptake rate into proteoliposomes
containing internal ornithine (ornithine/ornithine antiport) was
measured as dependence of the reagent concentration; in the
case of NH2-reagents the [
14C]citrulline uptake (ornithine/
citrulline antiport) was assayed, since these reagents may react
with the y-amino group of ornithine, thus reducing the
concentration of free ornithine. The IC50 values are listed in
Table 1. The carrier showed an IC50 in the millimolar range for
all the reagents with the exception of pOHMB and MTSEA;
the IC50 for these inhibitors was in the micromolar range (Table
1 and see Ref. [13]). These data indicated that, besides
sulfhydryl groups also amino groups of lysine, carboxyl groups
of glutamate/aspartate and guanidino groups of arginine are
related with the transport function.
Fig. 1. Kinetic analysis of the inhibition of the reconstituted ornithine/citrulline
carrier by NEM, MTSEA, PLP, using the Lineweaver –Burk plot. The
dependence of antiport rate was measured as [3H]ornithine or [14C]citrulline
uptake into proteoliposomes as described in Materials and methods. 0.1 mM
NEM (A), 0.3 AM MTSEA (B), 12 mM PLP (C) were added to the
proteoliposomes simultaneously with (.) or 4 min before (g) the substrate; (o)
control without inhibitor. Similar results were obtained in three different
experiments.
Table 1
Inhibitors of the ornithine/citrulline carrier
Inhibitor Target functional group IC50
NEM SH 0.16 mMT0.02 (from Ref. [13])
p-OHMB SH 0.59 AMT0.06 (from Ref. [13])
MTSEA SH 0.17 AMT0.03 (from Ref. [13])
Diamide SH 1.1 mMT0.4
PLP NH2 6.2 mMT1.05
SITS NH2 1.5 mMT0.3
DIDS NH2 0.15 mMT0.04
Methylglyoxal guanidino 7.3 mMT0.4
WRK COOH 1.8 mMT0.1
EDC COOH 4.3 mMT1.1
The IC50 values were derived from semilogarithmic plots of dose– response
curves for the inhibition of the reconstituted ornithine/citrulline carrier.
Inhibitors were added to the proteoliposomes 2 min before the addition of
0.1 mM [3H]ornithine or [14C]citrulline (in the case of the analysis of the
inhibition by PLP, SITS and DIDS). The transport was stopped after 1 min as
described in Materials and methods. The IC50 values are meansTS.D. from
three experiments.
A. Tonazzi et al. / Biochimica et Biophysica Acta 1718 (2005) 53–60 553.2. Relationships of amino acid functional groups with the
active site
To verify whether the functional groups of the ornithine/
citrulline carrier modified by the specific inhibitors have
some relationships with the active site, the influence of the
substrate on the extent of the inhibition was tested. We
found that 10 mM ornithine or 20 mM citrulline, added to
the proteoliposomes before the reagents, exerted a protection
of the transport inhibition. A protection of about 70% was
found towards NEM, p-OHMB, MTSEA and PLP; whereas
a protection lower than 40% was found towards diamide
and WRK; no protection was observed on the inhibition by
methylglyoxal (experiments not shown). For a more reliable
characterization of the relationships among the functional
groups sensitive to the reagents and the substrate binding
site, an inhibition kinetic study was performed. This was
possible since a competitive behaviour can be found also in
the case of covalent inhibitors, when the inhibitors interact
with the substrate binding site. However, in the case of
covalent inhibitors, the competitive effect will disappear, in
favour of the expected non-competitive inhibition, after
incubation of the inhibitors with the protein for longer
times [24–26]. Thus, the dependence of the antiport rate on
the substrate concentration, was studied in the absence and
presence of the inhibitor added simultaneously with the
substrate or added before the substrate (longer incubation
times). The analysis was performed with the SH reagents
NEM and MTSEA, with the disulphide inducer diamide,
with the NH2 reagent PLP that is highly specific for lysine
(differently from DIDS or SITS, that may react also with
SH groups [19,20,27]) and with WRK that is specific for
COOH groups. The experimental data, analysed according to
Lineweaver–Burk, gave competitive inhibition patterns for
NEM (Fig. 1A), MTSEA (Fig. 1B), PLP (Fig. 1C) added
together with the substrate; differently, non-competitive
patterns were obtained when the same inhibitors were added
4 min before the substrate. The same inhibition pattern wasfound for p-OHMB (not shown). The data indicate that,
under initial velocity condition, the inhibitors interfere with
the substrate binding to the active site. However, a problem
may arise in the case of partially competitive inhibition, i.e.,
the inhibitors bind to a site different from that of the
substrate causing an enzyme conformational change which
alters the binding of the substrates. This situation cannot be
Fig. 2. Kinetic analysis of the inhibition of the reconstituted ornithine/citrulline
carrier by NEM, MTSEA, PLP, using the Dixon plot. NEM (A) or MTSEA (B
was added at the indicated concentrations to proteoliposomes simultaneously
with 0.1 (.) or 0.3 (o) mM 3H-ornithine; PLP (C) was added at the indicated
concentrations to proteoliposomes simultaneously with 0.8 mM (.) or 3.0 mM
(o) [14C]citrulline. The antiport rate was measured as described in Materials
and methods. Similar results were obtained in three different experiments.
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problem can be resolved by varying the inhibitor concen-
tration at fixed substrate concentrations and plotting the
results according with the method of Dixon [26,28,29]. The
data analysed with this method give a non-linear dependence
in the case of partial inhibition. The Dixon plots obtained
using either NEM (Fig. 2A), MTSEA (Fig. 2B) or PLP
(Fig. 2C) showed a linear dependence indicating that the
inhibition is completely competitive. These results show that
the binding of the inhibitors occurs in or near the substrate
binding site. In the case of WRK (Fig. 3A) and diamide
(that induces the oxidation of two vicinal cysteines to form
a S–S bridge; Fig. 3B) added together with the labelled
substrate, the common interception of the straight lines in
Lineweaver–Burk plots fell between the axis, indicating a
mixed type of inhibition; when the same inhibitors were
added before the labelled substrate, non-competitive inhibi-
tion was found for WRK and again mixed inhibition for
diamide.
3.3. Titration of the SH groups in the active site
Due to the chemical properties of NEM, it was possible to
study the inactivation kinetics [26], i.e., the time dependence of
the inhibition of the carrier with NEM. This reagent, in fact,
differently from the other SH reagents here tested, leads to an
irreversible alkylation of the SH group(s); thus, its reaction
with the protein can be promptly stopped by DTE, that
inactivates the unreacted NEM molecules, without affecting the
formed NEM-protein adduct. This approach can give informa-
tion on the number of SH residues that must be derivatized to
inactivate the protein [26,30,31]. The dependence of the
residual carrier activity on the time of incubation with various
NEM concentrations was analysed in a semi logarithmic plot:
non-linear dependence of the Log of residual activity vs. time
was found at each NEM concentration (not shown), indicating
a complex interaction between the reagent and the protein.
However, by performing the same experiment at pH 7.0 instead
of pH 8.0, a pattern of straight lines was obtained (Fig. 4A);
from the slope of the lines, the apparent first-order rate
constants of the inactivation reaction of the protein with
NEM were derived. From the slope of the double-logarithmic
plot (Fig. 4B) a reaction order of 0.75 was calculated. This
result indicated that the modification of a single sulfhydryl
group, per functional carrier molecule, is sufficient for the
complete inhibition of the transport catalysed by the ornithine/
citrulline carrier. By performing the experiment described in
Fig. 1A at pH 7.0 instead of pH 8.0, the same competitive
pattern was obtained in the case of the inhibitor added together
with the labelled substrate (not shown).
3.4. Interaction between PLP and sulfhydryl reagents
On the basis of the results above described, one SH and
at least one NH2 functional groups must be located into the
substrate binding site of the ornithine/citrulline carrier. It
may be hypothesized that the two groups are located at an)appropriate distance to interact with the functional groups of
the substrate ornithine (or citrulline). Since the maximal
distance of the ornithine functional groups (y-amino and
carboxyl groups) is about 7.5 A˚, it can be expected a steric
hindrance between the amino and the sulfhydryl reagents if
both of them interact with the residues of the active site.
The experimental approach to verify this hypothesis was
Fig. 4. Kinetic of inactivation of the reconstituted ornithine/citrulline carrier by
NEM. (A) Proteoliposomes were incubated with different NEM concentrations
(n, 0.6 mM; o, 1 mM; g, 1.4 mM; ., 2 mM) for the indicated times. The
reaction of the inhibitor with the protein was stopped by the addition of 3 mM
DTE. The incubation with NEM and the transport measurement were
performed at pH 7.0 (see Results). (B) Double-logarithmic secondary plot of
the apparent inactivation constants Kapp plotted versus the applied concentra-
tions of NEM. Similar results were obtained in three different experiments.
Fig. 3. Kinetic analysis of the inhibition of the reconstituted ornithine/citrulline
carrier by WRK and diamide, using the Lineweaver –Burk plot. The
dependence of antiport rate was measured as [3H]ornithine uptake into
proteoliposomes as described in Materials and methods. 1 mM WRK (A)
and 0.5 mM diamide (B) were added to the proteoliposomes simultaneously
with (.) or 4 min before (g) the substrate; (o) control without inhibitor.
Similar results were obtained in three different experiments.
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PLP, but not the linkage of the SH reagents with the
reconstituted protein by size exclusion chromatography. The
virtually complete inhibition caused by 20 mM PLP (see
legend to the Table 2) could be reversed by Sephadex
chromatography (Table 2); on the contrary, the inhibition
caused by treatment of the proteoliposomes with HgCl2
NEM, pOHMB, MTSEA and diamide could not be
reversed. To test the possible interference among PLP and
the SH reagents, proteoliposomes were incubated with 20
mM PLP, and then with HgCl2, NEM, pOHMB, MTSEA or
diamide. After the treatment with both the reagents, the
proteoliposomes were passed through Sephadex G-75 to
remove the non-reacted reagents and reverse the PLP–
protein linkage. The treatment with PLP before the SH
reagents, prevented the inhibition by HgCl2, NEM, pOHMB,
MTSEA; this effect was proportional to the size of the SH
inhibitor: the prevention was lower with the smaller reagents
HgCl2 and NEM and higher with the larger reagents
MTSEA and pOHMB. These data clearly indicated the
occurrence of interference among the SH reagents and PLP,i.e., the amino and the sulfhydryl groups of the active site
have some spatial relationships. The inhibition by diamide
was not influenced by the preincubation of the protein with
PLP, indicating that the vicinal SH groups are not located in
the same environment of the NH2 group of the active site.
3.5. Homology model of the ornithine/citrulline carrier based
on the X-ray structure of the ADP/ATP carrier
The mitochondrial ornithine/citrulline carrier is homologous
with the bovine mitochondrial ADP/ATP carrier, for which a
crystal structure is available [14]. The two carriers share 20%
identical amino acids (not shown). We therefore built a
homology model of the mouse ornithine/citrulline carrier
(Fig. 5) based on the three-dimensional structure of the
carboxyatractyloside-ADP/ATP carrier complex. The figure
shows a view of the structure from the cytosolic side, as
deduced by the exposure of the N- and C-terminal ends of the
protein, typical of the carrier family [4,14]. In Fig. 5B, the
accessibility of the highlighted residues from the external
(cytosolic) side of the carrier is evidenced by the space-filled
Fig. 5. Structural model of the ornithine/citrulline carrier. (A) Ribbon diagram
viewing the carrier from the outside (cytosolic face); the following residues are
highlighted: Cys-132, Cys-23 and Cys 125 (red); Cys-50, Cys-51 and Cys-84
Cys-88 couples (light blu); Lys -34, Lys-131, Lys-234 (green); the matrix
hydrophilic loops are colored in dark gray. (B) Space-fill diagram of the same
picture of panel A.
Table 2
Interaction of PLP with sulfhydryl reagents in the inhibition of the reconstituted
ornithine/citrulline carrier
Additions at Residual activity after
0 min 5 min
Sephadex (% of the control)
PLP (20 mM) 110T3
HgCl2 (2 AM) 9T5
NEM (1 mM) 3T1
pOHMB (2 AM) 7T4
MTSEA (2 AM) 8T5






Proteoliposomes (400 Al aliquots) were incubated, at time zero, with the
reagents, at the indicated concentrations. At 5 min, aliquots of PLP incubated
proteoliposomes were added with the different sulfhydryl reagents. At 10 min,
all the proteoliposome samples were passed onto G-75 Sephadex columns
(0.715 cm) and than assayed for the transport measurements as described in
Materials and methods. Transport was started by adding 0.1 mM [3H]ornithine
and stopped after 10 min. Percent residual activity was calculated for each
sample with respect to the control (referred as 100%), i.e., proteoliposomes not
treated with any inhibitor; the values are meansTS.D. of the percentage of three
experiments. In the three experiments analysed: the residual transport activity
before G-75 Sephadex chromatography, of the sample treated with 20 mM PLP,
was 7T5% of the control; the average specific activity of the control samples
was 2.05T0.95 mmol/10 min/g protein.
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of the water filled cone-shaped cavity of the carrier and is fully
accessible to the outside (cytosolic side).
4. Discussion
In order to gain information on the role of specific amino
acid residues in the translocation pathway of the mitochondrial
ornithine/citrulline carrier, we have analysed the effect of
reagents specific for arginine, lysine, cysteine, aspartate/
glutamate. The substrate antiport catalysed by the carrier was
completely inhibited by each of the compounds tested,
externally added to the proteoliposomes, even though with
different efficiency. Thus, there are arginine, lysine, cysteine,
aspartate and/or glutamate responsible for the inhibition of the
transport activity. The differences in IC50 among the various
reagents may be determined by two main factors: (i) the
mechanism of reaction of the compounds with the protein; (ii)
the more or less favourable interaction of each reagent with the
surroundings of the functional group specifically derivatized.
Also, the alternative (ornithine/H+) transport mode of the
ornithine/citrulline carrier was inhibited by the reagents
indicating that similar transport pathways are involved in the
two modes of functioning of the protein; differently, none of
the inhibitors tested, was able to block the unphysiological
pore-like function of the ornithine/citrulline carrier (experi-
ments not shown). When studying the relationships between
specific amino acid residues and the function of a protein, it is
important to asses whether the residue responsible for the
inhibition is located into the substrate binding site. Thiscondition may be evidenced by substrate protection of the
inhibition, even though, this experimental approach can be
ambiguous due to possible conformational changes caused by
the inhibitor reaction with the protein, that can modify the
relationships among amino acid residues in the substrate
binding site. A more accurate procedure that indicate the
interaction of a molecule with the substrate binding site, is the
kinetic analysis of the inhibition. This type of analysis leads to
reliable results in the case of reversible inhibitors. However,
when the inhibitor combines with a substrate binding group in
the active centre, a competitive type of inhibition can be
observed also with covalent inhibitors. This happens if the
irreversible reaction of the inhibitors with the protein is slower
than the binding of the substrate; in this case the interaction of
the substrate with the active site slows down the velocity
constant of the inhibition and the competitive effect is evident
[24–26]. Therefore, a competitive inhibition found with,
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the substrate binding site. Most of the molecules here used
required more than 2 min for maximal inhibition under the
experimental conditions used (not shown and see Fig. 4). Thus,
the reaction of the inhibitors with the carrier is slower than the
binding of the substrate. The inhibition by sulfhydryl and
amino group reagents of the substrate antiport, analysed under
initial velocity condition, was clearly competitive. The
occurrence of a complete competitive inhibition was confirmed
by the linear Dixon-plots which exclude that the inhibitors may
react far from the binding site inducing conformational changes
in the active site [26,28,29]. The inhibitory effects observed are
determined by the reagent externally added to the proteolipo-
somes; thus, the specific amino acid residues implicated in the
inhibition must be exposed towards the external compartment
of the vesicles that corresponds to the cytosolic side of the
carrier, since the reconstituted protein has the same orientation
as in the mitochondrial membrane [9].The inactivation kinetic
analysis showed that the inhibition of the transport is related to
a 1:1 reaction of NEM with the protein, i.e., a single SH group
in the active site is responsible of the inhibition. This
stoichiometry was clearly measurable at pH 7.0; a non-linear
dependence was found at more alkaline pH; this may be
determined by the reaction of NEM with more than one SH,
under the condition of the experiment, i.e., prolonged time of
incubation. This is in agreement with previous data showing
that the ornithine/citrulline carrier possesses a population of SH
groups, related with the transport inhibition, constituted by at
least two Cys: the first of which with higher affinity for NEM
and the second with a lower affinity [13]. As previously
hypothesized [9], the SH of the active site can be involved as
thiolate, in the binding with H+, that is co-transported with
citrulline, the second substrate of the carrier that binds to the
same site of ornithine [9]. The same thiolate may be implicated
in the interaction with the y-amino group of the ornithine+
cation; this interaction will facilitate the dissociation of an H+
from ornithine+, thus forming uncharged ornithine that is the
substrate form required by ornithine transcarbamoylase in the
mitochondrial matrix [6,32]. No information about the number
of NH2 functional groups present in the active site can be
obtained by the inactivation kinetic approach used for the SH
groups, due to the reversible nature of the aldimine linkage
between PLP and the protein (see Table 2). However, it is
likely that a single NH2 group of Lys may be related to the
interaction with the carboxyl group of the substrate ornithine
(or citrulline). If the thiolate and the NH2 present in the active
site interact, respectively, with the y-amino and the carboxyl
groups of ornithine (see above), the distance between the two
functional groups of the protein, should be similar to the
distance between the functional groups of ornithine (about 7.5
A˚). On this basis, we have hypothesized to find sterical
hindrance between two reagents which bind specifically to the
amino or sulfhydryl group. Indeed, we have found an
interference among PLP and sulfhydryl reagents, evidenced
as prevention of the binding of the SH reagent by PLP (see
Table 2). Interestingly, the extent of prevention depends on the
size of the sulfhydryl reagents. After PLP binding, nearly noreaction of the larger pOHMB and MTSEA (6.9 and 6.6 A˚)
with the protein occurred; whereas about 30% or 50% of
reaction (inhibition) was detected for NEM (4.1 A˚ ) and HgCl2
(from 1 A˚, Hg++, to 2.4 A˚, Hg Cl2), respectively. On the basis
of these observations, we can hypothesize that the distance
between the two functional groups in the active site may be
comparable to the size of PLP (about 7.5 A˚). Few information
could be deduced by the inhibition of WRK and diamide
(mixed). It cannot be excluded that WRK could react, besides
other COOH, with a carboxyl group in the active site (see also
below). Regarding the mixed inhibition found with the
disulphide inducing reagent diamide, it may be hypothesized
that the formation of the disulphide causes a reduction of
mobility of the protein that impedes the conformational
changes of the active site responsible for the catalytic cycle
of the transport. On the basis of the absence of interference
between diamide and PLP (Table 2) and of results previously
reported (the S–S forming Cys and the SH derivatized by
NEM belong to different populations) [13], it is unlikely that
even one of the SH groups of the S–S forming Cys is located
in the active centre as the other Cys residue. This is also
supported by the structural model discussed below.
To gain further information about structure/function rela-
tionships of the ornithine/citrulline carrier we have modelled
[33–35] the structure of the carrier protein, using as template
the mitochondrial ADP/ATP carrier [14]. On the basis of the
structural model of the ornithine/citrulline carrier, Cys-132,
located on the 3rd transmembrane a-helix facing to the centre
of the aqueous cavity, can be identified as the Cys residue of
the active site, for the following reasons: (i) its SH group is
fully accessible towards the external (citosolic) side of the
carrier (Fig. 5B); thus, it can be reached by NEM, but also by
the hydrophilic reagents MTSEA and p-OHMB; (ii) Glu-128
residue is located at about 5 A˚ from Cys-132. This distance
corresponds to the size of the reacted MTSEA, which positive
charge can be stabilized by the negative charge of Glu; this is in
agreement with the highest affinity of the carrier for MTSEA
(Table 1 and see Ref. [13]); (iii) on the basis of the structural
model, at least one Lys residue (Lys-34, 131 or 234) lies in the
aqueous cavity at a distance of about 7 A˚ to the SH group of
Cys-132, in agreement with the size of the ornithine and PLP
molecules (see above); (iv) Cys-132 is homologous to the Cys-
136 residue located in the active site of the carnitine/
acylcarnitine carrier [36,37]. At least one of the three Lys
residues mentioned above is responsible for the competition
with the substrate (Fig. 1C) and the interference with the SH
reagents (Table 2). The alignment of the ornithine/citrulline
carrier with the yeast ornithine carrier ARG-11 [2] (not shown)
reveals that the residues corresponding to Cys-132, Lys-34,
131 and 234 are conserved; this finding is in agreement with
the role of some of these residues in the interaction with the
substrate. The further Cys residue(s) of the first population of
the ornithine/citrulline carrier that can react only with NEM at
higher concentrations and longer times of incubation but not
with MTSEA [13], are, most probably, Cys-23 and Cys-125;
these residues are located at the edge of the water cavity and, as
shown by the model (Fig. 5B), have a lower accessibility than
A. Tonazzi et al. / Biochimica et Biophysica Acta 1718 (2005) 53–6060Cys-132. Regarding the S–S forming Cys, that belong to a
different SH population [13], they could be identified with the
Cys couples Cys-84/Cys-88 and Cys-50/Cys-51 (Fig. 5A) that
are close enough to form S–S. However, when looking to the
space-fill model, these residues are not easily accessible from
the outside; in fact, Cys-84 and Cys-88 lies towards the
membrane; Cys-50 and Cys-51 are on an internal loop that,
however, is not far from the hypothetical substrate binding site.
These observations explain the very slow reaction of diamide
(see above and Ref. [13]) and, possibly, the mixed type of
inhibition found with this reagent.
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